We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$706B
AUM Growth
-$5.71B
Cap. Flow
-$2.17B
Cap. Flow %
-0.31%
Top 10 Hldgs %
21.49%
Holding
2,592
New
52
Increased
1,566
Reduced
801
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 15.83%
3 Financials 13.92%
4 Consumer Discretionary 13.43%
5 Industrials 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHTC icon
2201
Natural Health Trends
NHTC
$15.4M
$380K ﹤0.01%
53,710
VPG icon
2202
Vishay Precision Group
VPG
$908M
$379K ﹤0.01%
11,576
+53
+0.5% +$1.89K
ACRE
2203
Ares Commercial Real Estate
ACRE
$264M
$378K ﹤0.01%
24,832
+170
+0.7% +$2.59K
RESI
2204
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$378K ﹤0.01%
32,697
+297
+0.9% +$3.44K
AMAG
2205
DELISTED
AMAG Pharmaceuticals
AMAG
$376K ﹤0.01%
32,586
+19,923
+157% +$210K
FCBC icon
2206
First Community Bankshares
FCBC
$933M
$374K ﹤0.01%
11,560
+71
+0.6% +$2.32K
COLL icon
2207
Collegium Pharmaceutical
COLL
$913M
$371K ﹤0.01%
32,352
+190
+0.6% +$2.17K
PETS icon
2208
PetMed Express
PETS
$43.4M
$368K ﹤0.01%
20,408
+340
+2% +$5.61K
TILE icon
2209
Interface
TILE
$2.24B
$368K ﹤0.01%
25,488
+258
+1% +$3.38K
CAMP
2210
DELISTED
CalAmp Corp.
CAMP
$367K ﹤0.01%
1,385
+8
+0.6% +$1.97K
UNFI icon
2211
United Natural Foods
UNFI
$2.94B
$366K ﹤0.01%
31,773
+202
+0.6% +$1.93K
HABT
2212
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$366K ﹤0.01%
41,879
+104
+0.2% +$975
UTL icon
2213
Unitil
UTL
$992M
$364K ﹤0.01%
5,744
+81
+1% +$4.85K
WLFC icon
2214
Willis Lease Finance
WLFC
$1.15B
$364K ﹤0.01%
19,707
+42
+0.2% +$847
CWEN.A
2215
DELISTED
Clearway Energy Class A
CWEN.A
$363K ﹤0.01%
20,910
+223
+1% +$3.76K
NEO icon
2216
NeoGenomics
NEO
$2.11B
$363K ﹤0.01%
19,003
+601
+3% +$14.1K
CHEF icon
2217
Chefs' Warehouse
CHEF
$4.57B
$361K ﹤0.01%
8,965
+116
+1% +$4.34K
FC icon
2218
Franklin Covey
FC
$227M
$361K ﹤0.01%
10,328
+47
+0.5% +$1.7K
DBD
2219
DELISTED
Diebold Nixdorf Incorporated
DBD
$361K ﹤0.01%
32,203
-7,876
-20% -$93.3K
CNBKA
2220
DELISTED
Century Bancorp Inc/Mass
CNBKA
$360K ﹤0.01%
4,115
+16
+0.4% +$1.35K
GPRO icon
2221
GoPro
GPRO
$117M
$359K ﹤0.01%
69,266
+539
+0.8% +$2.53K
WLDN icon
2222
Willdan Group
WLDN
$1.29B
$359K ﹤0.01%
10,232
+51
+0.5% +$1.82K
RVNC
2223
DELISTED
Revance Therapeutics, Inc.
RVNC
$359K ﹤0.01%
27,593
+247
+0.9% +$3.02K
SKYW icon
2224
Skywest
SKYW
$4.21B
$356K ﹤0.01%
6,203
+244
+4% +$14.3K
USCR
2225
DELISTED
U S Concrete, Inc.
USCR
$356K ﹤0.01%
6,435
+78
+1% +$3.65K

Similar funds

T. Rowe Price Associates's Q3 2019 Portfolio in Review

As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
  • T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
  • T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
  • T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
  • T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
  • T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.

Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.